Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Publication year range
1.
Spinal Cord Ser Cases ; 2: 15001, 2016.
Article in English | MEDLINE | ID: mdl-28053726

ABSTRACT

INTRODUCTION: Posterior reversible encephalopathy syndrome (PRES) is an entity characterized by neurologic symptoms such as headaches, altered mental status, seizures and visual changes, and it is associated with white matter vasogenic edema predominantly affecting the posterior occipital and parietal lobes of the brain. CASE REPORT: A 19-year-old patient developed PRES after the use of chemotherapy for a testicular teratocarcinoma and after the development of a blood pressure elevation. DISCUSSION: Few cases described the involvement of the spinal cord in this syndrome. In the majority of these cases, the spinal cord involvement was asymptomatic or with few symptoms of spinal cord disease.

3.
J Chemother ; 23(3): 135-9, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21742581

ABSTRACT

The aim of this study was to identify phenotypic changes in a laboratory-derived strain of ertapenem-resistant Escherichia coli (Ec-ERT) when compared to its susceptible parent strain (Ec-WT). In both strains, we assessed both the effects of ertapenem via time-kill curves and the occurrence of cross resistance with other beta-lactams. The strains were compared based on growth pattern, biochemical-physiological profile and changes in the subproteome using 2D-DIGE followed by MALDI-TOF/TOF MS. To assess virulence, we employed a murine model of intraperitoneal infection in which we investigated the invasiveness of both strains. Growth persistence of the laboratory-derived resistant strain was observed via the time-kill curve assay, but cross resistance was not observed for other beta-lactams. We also observed a slower growth rate and changes in the biochemical and physiological characteristics of the drug-resistant bacteria. In the resistant strain, a total of 51 protein spots were increased in abundance relative to the wild-type strain, including an outer membrane protein A, which is related to bacterial virulence. The mouse infection assay showed a higher invasiveness of the Ec-ERT strain in relation to the Ec-WT strain. In conclusion, the alterations driven by ertapenem in E. coli reinforce the idea that antimicrobial agents may interfere in several aspects of bacterial cell biology, with possible implications for host-bacteria interactions.


Subject(s)
Anti-Bacterial Agents/pharmacology , Escherichia coli/drug effects , Escherichia coli/physiology , beta-Lactams/pharmacology , Animals , Bacterial Outer Membrane Proteins/metabolism , Drug Resistance, Bacterial , Ertapenem , Escherichia coli/metabolism , Escherichia coli/pathogenicity , Mice , Microbial Sensitivity Tests , Phenotype , Two-Dimensional Difference Gel Electrophoresis , Virulence , beta-Lactams/metabolism
5.
J Med Microbiol ; 49(4): 387-390, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10755636

ABSTRACT

To study the possible influence of intestinal micro-organisms on the course of strongyloidiasis in mice, a method was developed to obtain axenic infective larvae of Strongyloides venezuelensis. Cultured larvae from conventional mice were treated with sodium hypochlorite 0.25% for 10 min, washed in distilled water and then exposed to various combinations of antibiotics for 30 or 60 min. Success was achieved with a combination of penicillin 180 mg/L and ceftazidime 1 mg/ml. Decontamination of the larvae was determined by aerobic and anaerobic culture and by inoculation into gnotobiotic mice. Viability was established by subcutaneous inoculation of larvae into germ-free and conventional mice. Preliminary results showed that gnotobiotic mice were more susceptible than conventional mice to infection with axenic S. venezuelensis larvae as judged by faecal egg excretion, recovery of worms in the small intestine and histopathological examination of the duodenal mucosa. These results suggest that the normal intestinal flora protects the host against experimental infection with S. venezuelensis.


Subject(s)
Duodenum/parasitology , Strongyloides/pathogenicity , Strongyloidiasis/parasitology , Animals , Anti-Bacterial Agents/pharmacology , Disinfectants/pharmacology , Duodenum/microbiology , Duodenum/pathology , Feces/parasitology , Germ-Free Life , Larva , Mice , Mice, Inbred AKR , Parasite Egg Count , Sodium Hypochlorite/pharmacology , Strongyloides/drug effects , Strongyloidiasis/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...